Events
Two pharmaceutical companies and a medtech maker snagged three of the top-10 spots on Deloitte’s 2018 North America Technology Fast 500, a ranking of the fastest-growing North American companies in the fields of technology, life sciences, telecommunications, media and energy.
Winner SunRegen Healthcare is focused on innovative treatments for patients with neurodegenerative eye diseases
Oxford Immunotec Global PLC today announced that it plans to release third quarter 2018 financial results prior to market open on Friday, November 9, 2018.
Company to Participate in USA Corporate Executive Office Program
Company to Participate in USA Corporate Executive Office Program
iTeos Therapeutics SA today announced the presentation of two posters on its novel A2A receptor antagonist and TIGIT antibody programs, at the upcoming Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting, taking place from November 7-11, 2018 in Washington, D.C.
Society for Neuroscience Features OTO-413 Presentation as Neuroscience 2018 Hot Topic
Showcasing Antigen and Quality Assessment Products
Theranos fit in with the opaque culture of Silicon Valley, which allowed it to thrive and amass a fortune without delivering anything, book argues.
iX Biopharma Ltd will be presenting the positive results from the Phase 2 clinical KET010 study for Wafermine, its lead product under development for the treatment of moderate to severe acute pain at the Bio-Europe 24th Annual International Partnering Conference in Copenhagen, Denmark.
PRESS RELEASES